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Tristetraprolin (TTP) is a CCCH zinc finger-containing pro-
tein that destabilizes mRNA by binding to an AU-rich element.
Mice deficient in TTP develop a severe inflammatory syndrome
mainly because of overproduction of tumor necrosis factor .
We report here thatTTPalsonegatively regulatesNF-Bsignal-
ing at the transcriptional corepressor level, by which it may
repress inflammatory gene transcription. TTP expression
inhibited NF-B-dependent transcription. However, overex-
pression of TTPdid not affect reportermRNA stability. Instead,
TTP functioned as a corepressor of p65/NF-B. In support of
this concept, we found that TTP physically interacted with the
p65 subunit of NF-B and was also associated with HDAC1, -3,
and -7 in vivo. Treatment with histone deacetylase inhibitors or
small interfering RNA induced HDAC1 or HDAC3 knockdown
completely or partly abolished the inhibitory activity of TTP on
NF-B reporter activation. Consistently, chromatin immuno-
precipitation showed decreased recruitment of HDAC1 and
increased recruitment of CREB-binding protein on the Mcp-1
promoter in TTP/ cells compared with wild-type cells. More-
over, overexpression of TTP blocked CREB-binding protein-in-
duced acetylation of p65/NF-B. Taken together, these data
suggest that TTP may also function in vivo as a modulator in
suppressing the transcriptional activity of NF-B.
The transcription factor NF-B mediates the major inflam-
matory signal pathways and regulates the most inflammatory
gene expression (1). Excessive and prolonged activation of
NF-B can cause massive damage to host tissue and can result
in human inflammatory diseases such as atherosclerosis and
arthritis (2). Thus, the activation of NF-Bmust be terminated
through multiple mechanisms, including recruitment of tran-
scriptional corepressors (3–5).
TTP2 is an RNA-binding protein required for the rapid deg-
radation of mRNAs containing AU-rich elements (6). Targets
regulated by TTP include the mRNAs encoding TNF (7),
granulocyte-macrophage colony-stimulating factor (8), and
interleukin-2 (9), etc. Mice deficient in TTP develop an inflam-
matory syndrome characterized by cachexia, spontaneous
arthritis, dermatitis, and neutrophilia (10). The inflammatory
syndrome in TTP/mice is causedmainly by overproduction
of TNF, as neutralizing antibodies reactive with TNF pre-
ventmost of the inflammatory symptoms in TTP/mice (10).
Overexpression of TNF in TTP/mice may be explained by
its prolonged mRNA half-life, but other mechanisms may also
exist. Accumulating evidence indicates that TTP may have
additional functions besides influencing cytokinemRNAstabil-
ity. In Schizosaccharomyces pombe, a TTP-related protein is
required for effective transmission of a pheromone-induced
Ras/mitogen-activated protein kinase (MAPK) signal (11). In
addition, a nim/cdc25 mutant can be complemented by either
the Cdc2 kinase or a TTP/TIS11 gene, suggesting a cell cycle
effect (12). A TTP/TIS11-related protein in Saccharomyces cer-
evisiae is required for normal metabolism and retards cell
growth when overexpressed (13). TTP is induced during apo-
ptosis in response to the breast cancer susceptibility protein
BRCA1 (14). Furthermore, continuous expression of TTP at
physiological levels causes apoptotic cell death (15, 16). These
observations indicate that TTP protein might influence regula-
tory pathways that regulate survival, differentiation, or prolif-
eration. In a genome-wide analysis of TTP-affected glucocorti-
coid targets, the half-lives ofmanyTTP targetmRNAswere not
increased in TTP/ cells, suggesting a regulatory role for TTP
not limited tomRNA turnover (17). In addition, TTP is shuttled
between the cytoplasm and nucleus (18). It promotes mRNA
decay in the cytoplasm. However, what it does in the nucleus is
unknown.
We report here that TTP also negatively regulates NF-B
signaling at the transcriptional corepressor level. It suppresses
the transcriptional activity of p65/NF-B by recruiting HDACs
on theNF-B target gene promoters. These results suggest that
TTP may control the inflammatory response through multiple
mechanisms, including inhibition of transcription in the
nucleus and promotion of mRNA decay in the cytoplasm.
MATERIALS ANDMETHODS
Cells—Littermate wild-type and TTP/ day 14.5 embryos
were used to generate MEF cell lines 67/ and 66/, respec-
tively (provided by Dr. Perry J. Blackshear, NIEHS, NIH,
Research Triangle Park, NC). Cells were grown as a monolayer
inDulbecco’smodified Eagle’smedium (Invitrogen) containing
10% fetal bovine serum, 2 mM L-glutamine, and 100 units/ml
each penicillin and streptomycin. The mouse macrophage cell
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line RAW264.7 and HEK293 cells were cultured as described
previously (19).
Plasmids—The TNF-Luc reporter construct was kindly
provided by Dr. Dmitry V. Kuprash (Russian Academy of Sci-
ence) and was described previously (20). NF-B-TK-Luc was
purchased from Stratagene (La Jolla, CA). The pGL3-Control
vector was from Promega. HA-tagged TTP and TTP-C124R
expression plasmids were kindly provided by Dr. Perry J. Black-
shear. The pGal4-p65-(270–591) plasmid was kindly provided
byDr. Brian P. Ashburner (University of Toledo). Gal4-TK-Luc
and pcDNA-p65 were described previously (19). pGST-p65-
(1–305), pGST-p65-(245–355), and pGST-p65-(345–551)
were gifts from Dr. David R. Jones (University of Virginia).
FLAG-HDAC1, FLAG-HDAC2, FLAG-HDAC3, and FLAG-
HDAC7 were kindly provided by Dr. Ronald M. Evans (Salk
Institute). CMX-CBP and CMX-SMRT expression plasmids
were provided by the laboratory of Dr. Mangelsdorf. CMV-
FLAG-KNP1 was generated in this laboratory.
Reagents—Antibodies against phospho-IKK (Ser180), phos-
pho-IB (Ser32), acetyl-p65, HDAC1, HDAC3, CBP, and HA
tag were purchased from Cell Signaling Technology Inc. Anti-
p65/NF-B and anti-TTP (G-20) antibodies and siRNAs for
TTP, HDAC1, and HDAC3 were from Santa Cruz Biotechnol-
ogy. Anti-FLAG tag antibody, an anti-HA immunoprecipita-
tion kit, LPS (Escherichia coli 026:B6-derived), human recom-
binant interferon-, IL-1, and TNF were purchased from
Sigma. Anti-SMRT antibody was purchased fromAbcam. Glu-
tathione-Sepharose 4B was purchased from GE Healthcare.
Apicidin was purchased from BIOMOL.
Transfection—Transient transfection and luciferase assay
were performed as described previously (19).
Protein Isolation and Western Blotting—Protein isolation
and Western blotting were essentially performed as described
previously (19).
Co-immunoprecipitation—Co-immunoprecipitation assays
were performed by using an anti-HA immunoprecipitation kit
or a protein G immunoprecipitation kit (Sigma) following the
manufacturer’s instruction. Briefly, subconfluent HEK293 cells
on a 10-cm plate were transfected with 10 g of the indicated
combinations of expression vectors by the calcium phosphate
method. After 24 h, the transfected cells were left untreated or
treated with TNF for 15 min. Cells were lysed in CelLytic M
cell lysis buffer with protease inhibitors and phosphatase inhib-
itors. Cell lysates were incubated with anti-HA beads overnight
at 4 °C. After extensive washing, immunoprecipitated proteins
were resolved by 6–10% SDS-PAGE and analyzed by Western
blotting with anti-HA or anti-p65 antibodies.Membranes were
developedwith enhanced chemiluminescence (AmershamBio-
sciences). For endogenous immunoprecipitations, RAW264.7
cells were treatedwith LPS (1g/ml) for 0, 2, 4, and 8 h. The cell
lysates were incubated with anti-TTP polyclonal antibody or
rabbit anti-IgG as a control. The immune complexes were col-
lected by incubation (2 h, 4 °C) with protein G-agarose (Sigma).
Western blotting for detection of endogenous TTP, p65, and
HDAC1 was performed with anti-TTP, anti-p65, and anti-
HDAC1 polyclonal antibodies, respectively.
GST Fusion Protein Pulldown Assay—Plasmids pGST,
pGST-p65-(1–305), pGST-p65-(245–355), and pGST-p65-
(345–551)were transformed intoE. coliBL21 cells by theCaCl2
method. At A600  0.8, the cells were induced with isopropyl
-D-thiogalactopyranoside (0.2 mM final concentration) at
30 °C for 3 h and then lysed in buffer containing 25 mM Tris-
HCl (pH 7.4), 150 mM NaCl, 10% glycerol, 1 mM dithiothreitol,
protease inhibitormixture (CompleteMini, RocheApplied Sci-
ence), and 0.05% Triton X-100, followed by three 10-s pulses of
sonication. Glutathione-Sepharose CL-4B beads (GE Health-
care) were incubated with the lysates for 1 h. The beads con-
taining the bound GST-p65 fusion protein or the bound GST
protein were pelleted and extensively washed with lysis buffer.
Protein contents were quantified against known amounts of
bovine serum albumin on Coomassie Brilliant Blue-stained
SDS-polyacrylamide gels. Equal quantities of GST-p65 fusion
protein or GST protein bound to the glutathione-Sepharose
CL-4B beads were separately added to the precleared TTP-HA
cell lysates and incubated overnight at 4 °C. The bound proteins
from the TTP-HA-expressing cell lysates (pulldown assays)
were pelleted with the beads at 2000 rpm in a microcentrifuge,
washed, and separated on SDS-polyacrylamide gels. The sepa-
rated proteins were then analyzed by Western blotting with
anti-HAantibody to detect the pulled-downTTP-HA, followed
by Coomassie Brilliant Blue staining to confirm the presence of
GST protein or GST-p65 fusion protein in samples as
appropriate.
Chromatin Immunoprecipitation Assay—ChIP assay was
performed using the ChIP assay kit (Upstate Biotechnology)
according to themanufacturer’s instructions. The immunopre-
cipitation-enriched DNAwas quantified by real-time PCR, and
the values were normalized by the input DNA. The primers
used to amplify theMcp-1 promoter were 5-CACCCCATTA-
CATCTCTTCCCC-3 and 5-TGTTTCCCTCTCACTTCA-
CTCTGTC-3.
Statistics—Data are expressed as means S.D. For compar-
ison between two groups, the unpaired Student’s test was used.
For multiple comparisons, analysis of variance followed by the
unpaired Student’s test was used. A p value of 0.05 was con-
sidered significant.
RESULTS
TTPExpression Inhibits TNFPromoterActivity—TTP is the
prototypemember of a CCCH zinc finger protein family, which
down-regulates expression of many inflammatory genes by
destabilizing their mRNAs. Recently, we identified the novel
CCCH zinc finger protein MCPIP1 (MCP-1-induced protein
1), which down-regulates cytokine-induced TNF expression
by repressing its mRNA transcription but does not affect its
mRNA stability (19). In luciferase reporter experiments, TTP
was transfected to serve as a control. Surprisingly, we found
that overexpression of TTP strongly inhibited mouse TNF
promoter activity in a dose-dependentmanner in bothHEK293
and RAW264.7 cell lines (Fig. 1, A and B). Although TTP can
mediatemRNA stability, this is unlikely to explain the results in
Fig. 1 (A and B) because the mRNA transcribed from the
reporter construct lacked the AU-rich element associated with
TTP-mediatedmRNAdestabilization.Nevertheless, to exclude
this possibility, we determined the half-life of luciferase mRNA
under the influence of TTP. To accomplish this, HEK293 cells
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were transfected with the luciferase reporter driven by the
TNF promoter with or without the TTP plasmid and then
stimulated with IL-1 24 h after transfection. After 8 h of stim-
ulation, cells were treated with actinomycin D (10 g/ml), and
RNAwas harvested at serial time points as indicated. Luciferase
mRNA extracted from these samples was quantified by North-
ern blotting. As shown in Fig. 1 (C and D), TTP coexpression
did not influence the half-life of luciferasemRNA.These results
indicate that TTPmay regulate TNF expression at the level of
transcription.
TTP Inhibits NF-B-dependent Gene Activation—TNF
production is coordinately regulated by NF-B-, AP-1 (activa-
tor protein 1)-, and STAT-mediated signal pathways (20). To
further understand howTTP represses TNF transcription, we
tested whether TTP affects the activation of NF-B-, AP-1-,
and STAT-mediated signaling by luciferase assays. As shown in
Fig. 2A, TTP overexpression significantly inhibited the basal
and stimulus-induced NF-B activation in a concentration-de-
pendent manner. TTP did not affect the basal reporter activity
of STAT, but a high level of TTP transfection did reduce inter-
feron-- and LPS-induced STAT reporter activation as well as
phorbol 12-myristate 13-acetate-in-
duced AP-1 reporter activation
(data not shown). As it was noted
previously that TTP overexpression
leads to nonspecific “squelching” of
reporter constructs (7), we tested
the effect of TTP on an SV40-driven
control reporter. The same concen-
trations of the TTP plasmid did not
affect SV40 promoter-mediated
gene expression. To further confirm
that the suppressive effect of TTP
on the NF-B reporter is specific
rather than caused by “promoter
squelching,” we tested the effect of
the unrelated protein FLAG-KNP1
on the NF-B reporter. As shown in
Fig. 2C, expression of TTP signifi-
cantly inhibited TNF-induced
NF-B activation. However, expres-
sion of KNP1 did not affect NF-B
reporter activity at all. Expression of
both TTP and FLAG-KNP1 was
controlled by the cytomegalovirus
promoter. Their expression in the
transfected cells is shown in Fig. 2C
(lower panels). Interestingly, TTP-
C124R, the first zinc finger mutant
of TTP, also significantly repressed
TNF-induced NF-B activation
but was less potent compared with
the wild-type TTP protein (Fig. 2C).
To further explore the role of
endogenous TTP in NF-B regula-
tion, we transfected the NF-B
reporter into TTP/ and TTP/
MEFs. 24 h later, the cells were stim-
ulated with LPS (0.1 g/ml) or IL-1 (10 ng/ml) for 24 h. The
basal reporter activity was increased by 7-fold in TTP/MEFs
compared with TTP/ MEFs. LPS and IL-1 induced an
2-fold increase in reporter activity in both TTP/ and
TTP/MEFs (Fig. 2D). In addition, we observed the effect of
knockdown of TTP on NF-B-dependent gene expression by
using siRNA.These experimentswere performed inRAW264.7
cells transiently cotransfected with the NF-B reporter and
siRNA for TTP or the scrambled control and stimulated with
LPS (0.1 g/ml) for 24 h. As shown in Fig. 2E, LPS induced
NF-B reporter activity by 6.3-fold in RAW264.7 cells trans-
fected with scrambled control siRNA. The induction of NF-B
reporter activity was further increased by 11.2-fold in cells
transfected with TTP siRNA. Western blotting demon-
strated that the siRNA effectively reduced TTP protein levels
by60% relative to the control, whereas the internal control
-actin was not affected. Taken together, these results sug-
gest that TTP feedback controls LPS-induced NF-B
activation.
TTP Represses p65/NF-B Transactivation—To further
examine how TTP regulates NF-B signaling, we investigated
FIGURE 1.TTPexpression inhibits TNFpromoter activity.A and B, HEK293 or RAW264.7 cellswere cotrans-
fected with a luciferase reporter plasmid under the transcriptional control of the mouse TNF promoter and
increasing amounts of TTP-HA (0, 25, 100, and 400 ng/well). After being quiescent for 24 h, cells were treated
with orwithout IL-1 (10 ng/ml) or LPS (0.1g/ml) as shown and collected for analysis of reporter gene activity
24 h later. Data represent means S.D. from three independent experiments. *, p 0.05; **, p 0.01 versus
IL-1 stimulationwithout the TTP-HA-transfectedgroup. Thegels under the graph inA are theprotein levels of
TTP-HA and actin in the transfected cell lysates detected byWestern blotting. C, HEK293 cells were transiently
transfected with the pcDNA3.1 or pTTP-HA expression construct. After 24 h, the cells were quiescent for 18 h
and then treated with IL-1 (10 ng/ml) for 8 h, and actinomycin D (10g/ml) was added to stop transcription.
RNA was harvested after different time points as indicated. The luciferase (Luc.) mRNA level was examined by
Northern blotting. D, the intensity of the bands in Bwas quantified using an AlphaImager 2200 system (Alpha
Innotech). The value of the 0 point was set as 100%, and the values of the other points were transformed
according to the 0 point. The data from three independent experiments were averaged and plotted.
Tristetraprolin Represses NF-B
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the effect of TTP on IKK and IB phosphorylation. The
transfected HEK293 cells were quiescent and then stimulated
withTNF for various times as indicated. Thewhole cell lysates
were subjected to Western blot analysis using anti-phospho-
IKK and anti-phospho-IB antibodies. As shown in Fig. 3A,
there were no differences between TTP-overexpressing and
normal cells in the extent of TNF-induced IKK and IB
phosphorylation and degradation.
In addition, the overall protein con-
centration of NF-B p65 was not
affected by overexpression of TTP.
To determine whether TTP
represses p65/NF-B transactiva-
tion activity, NF-B-TK-Luc was
cotransfected with the expression
construct p65 and increasing
amounts of HA-TTP or SMRT (a
well known corepressor of NF-B
and other transcription factors) into
HEK293 cells. As shown in Fig. 3B,
expression of p65 activated NF-B-
dependent reporter expression by
32.8-fold. Expression of TTP re-
pressed this activation in a concen-
tration-dependent manner. Used as
a positive control, SMRTexpression
also markedly repressed p65-in-
duced NF-B reporter activation.
Overexpression of TTP and SMRT
in the transfected cells is shown in
Fig. 3B (lower panels).
p65/NF-B contains a TAD and a
Rel homology domain. To further
confirm that TTP affects the trans-
activation activity but not activation
and DNA binding of p65, we
cotransfected the Gal4 reporter
containing five copies of the Gal4-
binding site (Gal4-TK-Luc) with the
Gal4-p65(TAD) fusion construct
and increasing amounts of TTP-
HA. As shown in Fig. 3C, TTP also
dramatically suppressed Gal4-
p65(TAD)-activated reporter ex-
pression. These results suggest that
TTP may directly repress the p65/
NF-B transactivation domain.
TTP Physically Interacts with
p65—Next, we investigated wheth-
er TTP physically interacts with the
p65 subunit of NF-B.HEK293 cells
were transfected with p65 and
pTTP-HA expression plasmids.
24 h post-transfection, the cells
were untreated or treated with
TNF for 30 min. Protein extracts
were prepared and subjected to
immunoprecipitation with anti-HA
beads followed by immunoblotting with both anti-p65 and
anti-HA antibodies. As shown in Fig. 4A, TTP physically inter-
acted with p65 in untreated cells. TNF treatment reduced
TTP binding to p65. To further test whether endogenous TTP
protein is also associated with endogenous p65, RAW264.7
cells were treated with LPS (0.1 g/ml) for 0, 2, 4, and 8 h. The
cell lysateswere immunoprecipitated by anti-TTP antibody fol-
FIGURE 2. TTP represses NF-B-dependent gene expression. A and B, HEK293 cells were cotransfectedwith
the NF-B-TK-Luc (A) or pGL3-Control (B) vector as indicated with increasing amounts of pTTP-HA (0, 25, 100,
and 400 ng/well) by the calcium phosphate method. After being quiescent for 16 h, cells were treated with or
without TNF (10 ng/ml) (A) and collected for analysis of reporter gene activity 24 h later. *, p  0.01 versus
stimulationwithout the TTP-HA-transfectedgroup.C, HEK293 cellswere cotransfectedwithNF-B-TK-Lucwith
or without expression plasmids as indicated and subjected to the same treatment as described above. The
proper protein expression is shown in the lower panels. D, NF-B-Luc was transfected into TTP/ or TTP/
MEFsbyFuGENE6. 24h later, the cellswere stimulatedwith LPS (0.1g/ml) or IL-1 (10ng/ml) for another 24h.
The luciferase (Luc.) activitywasmeasured andnormalizedby-galactosidase activity. Thenumberoneachbar
represents -fold over the untreated group in TTP/ cells. E, scrambled control (siControl) or TTP (siTTP) siRNA
was cotransfected with NF-B-Luc into RAW264.7 cells by electroporation (Amaxa). 24 h later, the cells were
quiescent for 12 h and then stimulated with LPS (0.1 g/ml) for another 24 h. The luciferase activity was
measured and normalized by -galactosidase activity. The TTP and -actin protein levels in the transfected
cells were analyzed by Western blotting and are shown in the lower panels.
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lowed by protein G purification. Both whole cell extracts and
immunoprecipitates were subjected to Western blot analysis
with anti-TTP and anti-p65 antibodies. As shown in Fig. 4B,
endogenous TTP associated with p65 peaked at 4 h after LPS
stimulation but declined at 8 h after LPS stimulation. Consist-
ent with previous reports, TTP protein was significantly
induced by LPS (22). Taken together, these results suggest that
TTP can physically interact with p65, which is dynamically reg-
ulated by TNF and LPS.
To examine the TTP interaction region of p65, HEK293
lysates overexpressing TTP-HA were incubated with GST,
GST-p65-(1–305), GST-p65-(245–355), or GST-p65-(345–
551); washed; and separated on SDS-polyacrylamide gels.
The separated proteins were then analyzed by Western blot-
ting with anti-HA antibody to detect the pulled-down
TTP-HA followed by Coomassie Brilliant Blue staining to
confirm the presence of GST protein or GST-p65 fusion pro-
tein in samples as appropriate. As shown in Fig. 4C, TTP was
found to interact with GST-p65-(245–355) and GST-p65-
(345–551) but not GST-p65-(1–305). Thus, the C-terminal
region (positions 345–355) of p65 may be responsible for
binding to TTP.
Involvement of HDACs in the TTP-mediated Inhibitory Effect
on NF-B—As documented, the transactivation function of
NF-B is regulated through interaction with HDAC corepres-
sor proteins (23). By analogy, TTP may also associate with
HDACs. To test this possibility, FLAG-tagged HDAC1,
HDAC2, HDAC3, and HDAC7 were cotransfected with HA-
tagged TTP into HEK293 cells. Cell lysates of the transfected
cells were immunoprecipitated with HA-specific antibody and
subjected to Western blot analysis for HDACs and TTP. As
shown in Fig. 5A, HDAC1, HDAC3, and HDAC7 were readily
co-immunoprecipitatedwithTTP.HDAC2was not found to be
immunoprecipitated with TTP, which may be due to the low
expression of HDAC2 in whole cell extracts (Fig. 1A). The
interaction of endogenous HDACs with endogenous TTP was
also determined by co-immunoprecipitation. As shown in Fig.
5B, HDAC1 was specifically precipitated by anti-TTP antibody
but not by IgG or anti-SRA antibody in LPS-treated RAW264.7
cell extracts.
To determine whether TTP represses the transcriptional
activity of NF-B through HDACs, apicidin, a potent tetrapep-
tide HDAC inhibitor, was used to treat the transfectedHEK293
cells. As shown in Fig. 5C, TNF induced NF-B promoter
activation by 23-fold. Overexpression of TTP repressed its
activity to 7.5-fold. Interestingly, the inhibitory activity of TTP
on NF-B-mediated gene activation was completely abolished
in the presence of 500 nM apicidin. Thus, the inhibitory activity
of TTP onNF-B ismediated byHDACactivity. To further test
whether endogenous HDAC1 and HDAC3 mediate the inhibi-
tory effect of TTP on NF-B, HEK293 cells were cotransfected
with control, HDAC1, or HDAC3 siRNA and TTP-HA and the
NF-B reporter. 24 h after transfection, the cells were treated
with TNF for another 24 h. As shown in Fig. 5D, siRNA-me-
diated knockdown of HDAC1 or HDAC3 partly rescued the
effect of TTP on NF-B reporter activation. However, knock-
down of both HDAC1 and HDAC3 completely rescued the
effect of TTP on NF-B activation, suggesting that both
HDAC1 and HDAC3 are involved in the TTP-mediated inhib-
itory effect on NF-B. Western blotting demonstrated that the
specific siRNAs effectively reduced the protein expression of
FIGURE 3. TTP represses transactivation of p65. A, HEK293 cells were trans-
fected with pcDNA3.1 or pTTP-HA. After 24 h, the transfected cells were quies-
cent for 16 h and then stimulated with TNF (10 ng/ml) for the indicated times.
Whole cell extracts were isolated and subjected to Western blot analysis using
anti-phospho-IKK, anti-phospho-IB, anti-p65, or anti-HA antibody as indi-
cated. B and C, HEK293 cells were transfected with NF-B-TK-Luc, p65, and
increasingamountsofpTTP-HAas indicatedorSMRT(B)orwithGal4-TK-Lucwith
anexpressionconstruct encoding theGal4-p65(TAD) fusionprotein and increas-
ing amounts of pTTP-HA (C) as indicated. 36 h later, the cells were collected for
analysis of reporter gene activity and protein expression. *, p 0.01 versus stim-
ulationwithout the TTP-HA-transfected group. Luc., luciferase.
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HDAC1 and HDAC3 by 80% relative to control siRNA (Fig.
5D, lower panel).
It is well known that acetylation of p65 by CBP/p300 is associ-
ated with increased transcription without altering its binding to
DNA (24). To further explore howTTP represses p65 transactiva-
tion activity, we observed the effect of TTP expression on CBP-
inducedacetylationofp65.As shown inFig. 5E, cotransfectionCBP
induced p65 acetylation. Overexpression of TTP completely abol-
ished CBP-induced acetylation of p65. The results further support
that TTP may function as a transcriptional corepressor of p65 by
recruitingHDACs anddiminishing p65 acetylation.
Absence of TTPDecreasesHDAC1 but Increases CBPRecruit-
ment to theMcp-1 Promoter—It has been reported thatHDACs
and CBP are dynamically recruited to the NF-B target pro-
moter to precisely control gene expression. To further examine
the influence of endogenous TTP on the recruitment of
HDAC1 and CBP to theMcp-1 promoter, we performed ChIP
assay in TNF-treated TTP/ and TTP/ MEFs with anti-
HDAC1 and anti-CBP antibodies (Fig. 6). Consistent with the
results above, HDAC1 recruitment was significantly decreased
in TTP/ MEFs compared with TTP/ MEFs. In contrast,
CBP recruitmentwas increased inTTP/MEFs. As noted, the
absence of TTP did not affect the binding of p65 to theMcp-1
promoter. TTP recruitment on the Mcp-1 promoter was
induced by TNF in TTP/ cells. As expected, no TTP
recruitment was detected in TTP/ cells.
DISCUSSION
TTP is a tandem CCCH zinc finger protein that was charac-
terized as a destabilizing factor of inflammatory mRNAs (6). In
this work, we have provided evi-
dence that TTP also negatively reg-
ulatesNF-Bsignaling in anHDAC-
dependent manner. Using reporter
assays, we have shown that TTP
inhibits NF-B-mediated gene acti-
vation and that such an inhibitory
activity of TTP can be overcome by
suppressing HDAC activity or
expression. By in vivo co-immuno-
precipitation and GST pulldown,
TTP was found to physically inter-
act with the p65 subunit of NF-B
and to associate with HDAC1,
HDAC3, andHDAC7. Consistently,
TTP did not interfere with NF-B
signaling activation. Instead, TTP
diminished p65 acetylation. Fur-
thermore, knockdown of TTP
enhanced LPS-induced NF-B
reporter activation, which is con-
sistent with increased CBP recruit-
ment and decreased HDAC1
recruitment on the NF-B target
promoter in TTP/ cells. Com-
bined with many other reports,
these results suggest that TTP may
critically regulate inflammatory
gene expression through multiple mechanisms, including
mRNA transcription and decay. However, the precise mecha-
nisms by which TTP represses mRNA transcription are not
completely understood. Our studies suggest that TTP exerts
this effect at least partly through recruitment of HDACs to the
target promoter and diminishment of p65 acetylation. How-
ever, other mechanisms may also exist.
Consistent with previously reports, there is low level of TTP
protein in resting RAW264.7 cells. LPS treatment caused a
marked increase in TTP protein. However, the pattern of p65
co-immunoprecipitationwithTTPdid not follow the pattern of
TTP accumulation (Fig. 4B). It has been reported that LPS reg-
ulates TTP at both the transcriptional and post-transcriptional
levels. LPS-activated signaling pathways can dramatically
induce TTP expression, which could also induce phosphoryla-
tion of TTP (25). It was observed previously that p38-mediated
phosphorylation of TTP can shuttle TTP from the nucleus to
the cytoplasm and inhibit TTP binding to mRNA (26, 27). Our
results suggest that LPS stimulates the binding of TTP to p65 at
an early time point (4 h) by induction of TTP expression and
prevents TTP interaction with p65 at a late time point (8 h) by
phosphorylation. This may also explain why TNF treatment
reduced TTP interaction with p65 in the overexpressing cell
line (Fig. 4A). Interestingly, Zhu et al. (28) also observed that
p38-mediated TTP phosphorylation can release the suppres-
sive effect of TTP on TNF transcription.
Our results suggest that TTP may also negatively regulate
AP-1- and STAT-mediated signaling pathways, as overex-
pression of TTP also repressed AP-1 and STAT reporter
activity (data not shown). However, there is no direct asso-
FIGURE 4. TTP physically interacts with p65. A, HEK293 cells were transiently cotransfected with p65 with or
without the pTTP-HA expression plasmid. The transfected cells were stimulated with or without TNF for 30
min. The whole cell lysates (WCE) were subjected to co-immunoprecipitation (IP) with anti-HA antibody fol-
lowed by Western blotting with anti-p65 or anti-HA antibody. The same lysates were subjected to SDS-PAGE
and probed with anti-p65 or anti-HA antibody for proper protein expression. B, RAW264.7 cells were treated
with LPS (0.1g/ml) for 0, 2, 4, and 8 h. The cell extracts were subjected to immunoprecipitation with anti-TTP
antibody. Both whole cell extracts and immunoprecipitates were analyzed by Western blotting with anti-TTP
and p65 antibodies. C, HEK293 cells were transfectedwith the pTTP-HA plasmid. After 24 h of transfection, the
cellswere treatedwith TNF for 30min. Aliquots of cell lysateswere subjected topurificationwithglutathione-
Sepharose beads already bound to GST, GST-p65-(1–305), GST-p65-(245–355), or GST-p65-(345–551). Proteins
co-precipitated with GST beads were analyzed byWestern blotting with anti-HA antibody. Whole cell extracts
were also analyzed by Western blot analysis with anti-HA antibody to monitor the expression of transfected
DNA. Coomassie (Comas.) Brilliant Blue stain showed the expression of GST and GST fusion proteins.
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ciation of TTP with c-Fos/c-Jun or STAT1, suggesting that
TTP may repress AP-1- and STAT-mediated signaling path-
ways through different mechanisms.
One may ask whether the inhibi-
tory effect of TTP on NF-B signal-
ing is dependent on its RNA-desta-
bilizing activity. We observed that
the first zinc finger mutant of TTP
also significantly suppressed NF-B
activation with less potency com-
pared with the wild-type TTP pro-
tein. Because any zinc finger muta-
tion of TTP protein completely
loses its RNA-binding activity (29),
our data suggest that the effect of
TTP on NF-B signaling may be
independent of its RNA-destabiliz-
ing activity but that its two zinc fin-
gers may be required for transcrip-
tion repression.
As reported previously, expres-
sion of TTP not only causes apopto-
tic cell death but also sensitizes cells
to induction of apoptosis by TNF
(15, 16). However, the molecular
mechanisms underlying these
events are not clear. It was well
established that maturing activated
monocytes face a choice between
NF-B-dependent survival and
differentiation and death by
TNF-induced apoptosis. Our
results suggest that overexpres-
sion of TTP may promote TNF-
induced apoptosis through repres-
sion of NF-B signaling.
At least 55 CCCH zinc finger
genes exist in the human genome
(30). Although most of the CCCH
proteins have been less character-
ized, most of the characterized
CCCH proteins are RNA-binding
proteins and regulate RNAmetabo-
lism, including mRNA maturation,
export, modification, and turnover
(30). However, there are also some
CCCH proteins that regulate
mRNA transcription. For instance,
PIE-1 is a Caenorhabditis elegans
protein that contains two central
CCCH zinc fingers. PIE-1 can func-
tion as a transcription repressor by
targeting to the basic transcrip-
tional machinery (31). Recently, we
identified the novel CCCH protein
MCPIP1, which also represses
TNF transcription but does not
affect its mRNA stability (19). Actu-
ally, TTPwas also reported to interfere with the transcriptional
activity ofTax by directly interactingwithTax protein (32). Zhu
et al. (28) also observed that TTP can inhibit TNF and IL-8
FIGURE 5. Involvement of HDACs in the TTP-mediated inhibitory effect on NF-B. A, HEK293 cells were
cotransfected with pTTP-HA and the FLAG-HDAC1, FLAG-HDAC2, FLAG-HDAC3, or FLAG-HDAC7 expression
plasmid. After 24 h of transfection, thewhole cell lysates (WCE) were subjected to co-immunoprecipitation (IP)
with anti-HA antibody followedbyWestern blotting (immunoblotting (IB)) with anti-FLAGor anti-HA antibody
as indicated. The same lysateswere subjected to SDS-PAGE andprobedwith anti-FLAGor anti-HA antibody for
proper protein expression. B, RAW264.7 cells were treated with LPS for 8 h. The cell extracts were subjected to
immunoprecipitation by anti-TTP antibody, no specific IgG, or an unrelated antibody followedbyWestern blot
analysis with anti-TTP or HDAC1 antibody. The HDAC1 protein level in whole cell extracts was also probed by
anti-HDAC1 antibody. C, HEK293 cells were cotransfected with NF-B-TK-Luc and TTP-HA or the empty vector
as indicated. The transfected cells were treatedwith orwithout HDAC inhibitor (apicidin at 0.1, 0.2, and 0.5M)
for 2 h and then stimulated with TNF (10 ng/ml) for 24 h. Cells were collected for analysis of reporter gene
activity. The data are from three independent experiments (means  S.D.). *, p  0.01 versus TTP-HA-trans-
fected without the apicidin treatment group. D, HEK293 cells were transfected with scrambled control siRNA
(siControl), HDAC1 siRNA (siHDAC1), or HDAC3 siRNA (siHDAC3) together with NF-B-Luc and the TTP-HA
plasmid as indicated. 24 h later, the cells were quiescent for 12 h and then stimulated with TNF for 24 h. The
reporter activity was analyzed. The HDAC1 and HDAC3 protein levels in the cell lysates were detected by
Westernblot analysis. *,p0.01 versus the scrambled control siRNA- andTTP-HA-transfectedgroup. E, HEK293
cells were cotransfectedwith p65, CBP, and pTTP-HA as indicated. Cell lysates were extracted and analyzed by
Western blotting with anti-acetyl-p65, anti-p65, and anti-HA antibodies.
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promoter activity. Considering that TTP is a nucleocytoplas-
mic shuttling protein, these results strongly indicate thatTTP is
a candidate to couple transcription in the nucleus and mRNA
decay in the cytoplasm. In yeast, the RNA-binding protein
Rpb4/7 couples the two processes of transcription in the
nucleus and mRNA decay in the cytoplasm (21).
In summary, we report that TTP, an RNA-destabilizing pro-
tein, also functions as a transcriptional corepressor of NF-B.
These results suggest that TTP may critically control the
inflammatory response bymultiplemechanisms and is a poten-
tial therapeutic target for human inflammatory diseases.
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FIGURE6.ChIPanalysisof theMcp-1promoter inTTP/MEFs.ChIPassays
were performed with MEFs from wild-type (/) or TTP null (/) litter-
mates untreated or treated with TNF (10 ng/ml). Protein-DNA complexes
were immunoprecipitated with the indicated antibodies, and immunopre-
cipitatedDNAwas analyzedbyquantitative PCRwith specific primers against
the IB site in the murine Mcp-1 promoter. The values were normalized by
input DNA. The experiment was independently repeated twice with similar
results.
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